Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06347055 · ClinicalTrials.gov registry record · NA

NeuroControl of Nicotine Dependence

A NA study of Nicotine Dependence, sponsored by University of Missouri-Columbia.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06347055 is a NA study of Nicotine Dependence that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 30 participants, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06347055, a NA study of Nicotine Dependence, is actively recruiting participants, sponsored by University of Missouri-Columbia.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to examine the effects of continuous theta burst stimulation (cTBS) on different forms of cognitive control in adults who smoke cigarettes, and to determine if the location where cTBS is delivered may help smokers reduce or quit smoking. Participation in the study will take 3-weeks over 4 visits, with a total time commitment of approximately 12 hours.

Conditions Studied

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)

Study Locations (1)

Missouri

  • Health Neuroscience Center - Columbia

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-10-01
Est. Completion 2030-04-30
Phase NA

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT06347055

The ClinicalTrials.gov registry entry for NCT06347055 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (84% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.

NCT06347055 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT06347055 about?

NCT06347055 is a clinical study titled "NeuroControl of Nicotine Dependence". The purpose of the study is to examine the effects of continuous theta burst stimulation (cTBS) on different forms of cognitive control in adults who smoke cigarettes, and to determine if the location where cTBS is delivered may help smokers reduce or quit smoking. Participation in the study will ta...

What is the current status of trial NCT06347055?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-10-01. Estimated completion is 2030-04-30.

What conditions does trial NCT06347055 study?

This clinical trial studies the following conditions: Nicotine Dependence.

What interventions are being tested in trial NCT06347055?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE).

Who is sponsoring clinical trial NCT06347055?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06347055 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.